These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6873751)

  • 1. Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction.
    Doutremepuich C; Gestreau JL; Maury MO; Quilichini R; Boisseau MR; Toulemonde F; Vairel E
    Haemostasis; 1983; 13(2):109-12. PubMed ID: 6873751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the antithrombotic efficacy of four low-molecular-weight heparins in three different models of experimental venous thrombosis.
    Monreal M; Silveira P; Monreal L; Monasterio J; Angles AM; Lafoz E; Lorente L
    Haemostasis; 1991; 21(2):91-7. PubMed ID: 1660013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model.
    Doutremepuich C; Toulemonde F; de Seze O; Pereira F; Anne MC; Doutremepuich F
    J Leukoc Biol; 1987 Dec; 42(6):628-31. PubMed ID: 2824648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.
    Doutremepuich C; Bousquet F; Gestreau GL; Toulemonde F; Bayrou B
    Haemostasis; 1987; 17(4):201-5. PubMed ID: 3623263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
    Bratt G; Törnebohm E; Granqvist S; Aberg W; Lockner D
    Thromb Haemost; 1985 Dec; 54(4):813-7. PubMed ID: 3911482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis.
    Harenberg J; Huck K; Bratsch H; Stehle G; Dempfle CE; Mall K; Blauth M; Usadel KH; Heene DL
    Haemostasis; 1990; 20 Suppl 1():205-19. PubMed ID: 1964663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.
    Holm HA; Ly B; Handeland GF; Abildgaard U; Arnesen KE; Gottschalk P; Høeg V; Aandahl M; Haugen K; Laerum F
    Haemostasis; 1986; 16 Suppl 2():30-7. PubMed ID: 3527886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of clinical trials of low molecular weight heparin fractions.
    Levine MN; Hirsh J
    Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of heparin and related agents.
    Hladovec J; Kornalík F
    Cor Vasa; 1991; 33(1):68-74. PubMed ID: 1655354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass.
    Bianchini P; Bergonzini GL; Parma B; Osima B
    Haemostasis; 1995; 25(6):288-98. PubMed ID: 8586320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of biological activities of heparin and fraxiparine induced by the size and the age of a thrombus. Experimental study.
    Doutremepuich C; Llido S; Lalanne MC; Doutremepuich F
    Thromb Res; 1990 Aug; 59(3):439-47. PubMed ID: 2237821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.
    Carelli G; Maffei FH; Mattar L; Ferrari IC; Thomazini-Santos IA; de Carvalho LR
    Pathophysiol Haemost Thromb; 2005; 34(6):263-8. PubMed ID: 16772737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis.
    Lockner D; Bratt G; Törnebohm E; Aberg W; Granqvist S
    Haemostasis; 1986; 16 Suppl 2():25-9. PubMed ID: 3744133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi-Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis.
    Bratt GA; Törnebohm E; Johanson M; Aberg W; Granqvist S; Lockner D
    Acta Chir Scand Suppl; 1988; 543():96-100. PubMed ID: 2847465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activity of orally administered low molecular weight heparin (Logiparin) in a rat model.
    Hiebert LM; Ping T; Wice SM
    Haemostasis; 2000; 30(4):196-203. PubMed ID: 11155038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y; Honda Y; Kamisato C; Shibano T
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in man and experimental animals of a low molecular weight heparin fraction.
    Thomas DP; Merton RE; Lewis WE; Barrowcliffe TW
    Thromb Haemost; 1981 Jun; 45(3):214-8. PubMed ID: 7281101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.